Insider Transactions Reported by 7 Insiders of Hoth Therapeutics, Inc.

Symbol
HOTH on Nasdaq
Location
New York, NY

There are no Buy or Sell transactions made by insiders since 16 Mar 2025

Hoth Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robb Knie CEO and President, Director $662,338 27 Aug 2025
Wayne Linsley Director 19 Aug 2024
Jeff Pavell Director 19 Aug 2024
Christopher Michael Camarra Director 08 May 2025
David Sarnoff Director 19 Aug 2024
Stefanie Johns Chief Scientific Officer 16 Mar 2022
Graig Springer Director 14 Jan 2025

Recent Insider Transactions by Companies or Individuals for Hoth Therapeutics, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Robb Knie HOTH Common Stock Tax liability -36.2% -310,744 547,387 28 Aug 2025 Direct
Robb Knie HOTH Common Stock Award 1376.2% 800,000 858,131 27 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.